SUSAN GROSSLIGHT: Open Payments
NPI 1821100835 · WINNSBORO, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$811 in 44 payments from 16 companies in 2025. Trend: 2023 $868 · 2024 $697 · 2025 $811
Food & beverage: $811
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $149 |
| Amgen Inc. | 6 | $106 |
| Dexcom, Inc. | 3 | $105 |
| AstraZeneca Pharmaceuticals LP | 5 | $77 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $68 |
| Lilly USA, LLC | 3 | $55 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $47 |
| PFIZER INC. | 2 | $43 |
| Exact Sciences Corporation | 1 | $30 |
| Sumitomo Pharma America, Inc. | 1 | $25 |
Products named: Dexcom G6 Transmitter, OTEZLA, CAPLYTA, Ozempic, MOUNJARO, XIFAXAN, PREVNAR 20, The Cologuard Plus Collection Kit.
Industry payments across SC — which companies pay providers there.
